The present invention discloses bioengineered corneal grafts for treating either or both Keratoconus and visual impairment, selected from (i) a corneal Onlay comprises or coated by at least one member of Group A, consisting of biocompatible synthetic materials; at least one member of Group B, consisting of at least one type of biological polymer and optionally, at least one member of Group C, consisting of at least one type of protein and (ii) An intrastromal corneal lenticule graft, configured to mimic native corneal stroma tissue by means of its optical properties, mechanical properties, permeability and interaction with corneal stromal cells; wherein at least one portion of said lenticule comprises or coated by at least one member of Group D, consisting of transparent crosslinked hydrogel; at least one member of Group E, consisting of collagen; collagen methacrylate, recombinant mammal collagen, mammal-sourced collagen; and optionally, at least one member of Group F, consisting of Keratocytes and/or stem cells and any combination thereof. The present invention further discloses compositions, methods for production, implementation and treatment of medical indications by aforesaid corneal graft.

A method of forming and implanting a synthetic corneal lenslet in an eye of a patient includes the steps of: forming a synthetic lenslet from a collagen solution using a mold or a 3-D printer that are configured to form the synthetic lenslet into a predetermined shape for correcting a particular refractive error of the patient; forming a cavity for receiving the synthetic lenslet in the cornea of the eye of the patient; inserting the synthetic lenslet into the cavity of the eye; applying a photosensitizer into the cavity of the eye so that the photosensitizer permeates at least a portion of the tissue surrounding the cavity and at least a portion of the synthetic lenslet; and irradiating the cornea so as to activate cross-linkers in the synthetic lenslet and cross-linkers in the portion of the tissue surrounding the cavity, and thereby prevent an immune response.

The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.

A multifocal ophthalmic lens has an optic zone that includes at least one first zone having a dioptric power that satisfies a distance refraction need of a patient; and at least one second zone having a dioptric power that is greater than the dioptric power of the at least first zone. The at least one first zone and the at least one second zone are configured so that 1) an image quality on the retina of the patient is superior to the image quality both in front of the retina and behind the retina, and 2) an image quality in front of the retina of the patient is superior to the image quality behind the retina. The multifocal ophthalmic lens prevents and/or slows myopia progression.

A training cornea adapted to train physicians how to position a corneal inlay within a cornea, and methods thereof. The training cornea having a pre-made flap therein and having a base curvature with a radius of curvature that is the same as the radius of curvature training ball. The training cornea comprising a hydrophilic material.

An intraocular lens is configured to reduce or eliminate oblique incident light photic disturbances in the eye. The lens includes anterior and posterior surfaces defining a central lens optic extending from the anterior to the posterior surfaces and a peripheral portion outside of the central lens optic. The peripheral portion is a prismatic lens that redirects oblique incident light on the peripheral portion forward of the nasal retina in the eye and onto the ciliary body/pars plana region.

Lenses incorporate freeform power profiles that at least one of slow, retard or preventing myopia progression. An ophthalmic lens includes a first zone at a center of the lens; a first peripheral region continuously extending from the center, the first peripheral region having a different dioptric power than at the center; and a second peripheral region continuously extending from the first peripheral region and having a different dioptric power than the first peripheral region, thereby providing a continuous freeform power profile having substantially equivalent visual performance to a single vision lens, and having a depth of focus and reduced retinal image quality sensitivity that slows, retards, or prevents myopia progression.

This invention describes strategies and devices for improving the visual experience while expanding the depth of field of presbyopic and pseudophakic patients. The invention describes strategies and devices for providing improved image quality and improved visual quality of patients employing simultaneous vision bifocal, trifocal or multifocal corrections or monovision. The invention describes strategies and devices for reducing the visibility of the defocused part of the retinal image generated by simultaneous vision bifocal and multifocal ophthalmic corrections and monovision. The invention describes strategies and devices that employ control of spherical aberration or other similar asphericities to reduce the visibility of defocused ghost images. The invention describes strategies and devices that ensure that negative defocus is always coupled with negative spherical aberration (or similar asphericity), and that positive defocus is always coupled with positive SA (or similar asphericity) as a means to reduce the visibility of defocused ghost images.

Disclosed is an intrastromal insert, already preformed, of solid, transparent, impermeable, biocompatible, physiologically inert and chemically resistant material, with notches allowing the passage of metabolites, substances, cells or portions thereof, and drugs, configured to receive printing, which is adapted in the space of the corneal stroma to change the eye color and/or to solve the problem of insufficient pigmentation of the iris. The method and the related component to change, permanently and reversibly, the eye color for aesthetic purposes are described as well.

A method of inserting and securing a corneal implant in engaging and fluid-flow limiting relation to the posterior cornea, such as to treat edema. The method includes securing a corneal implant in fluid flow limiting relation to the posterior cornea through an incision in the eye and securing it in place by a variety of steps such as corneal insertion or laser bonding, and preferably by inserting a removable corneal implant including a central region and a plurality of retention member(s) disposed on the periphery thereof into the eye so as to releaseably and removably engage a portion of the eye and thereby retain the corneal implant in abutting and engaging relation with the posterior cornea. The retention members of the corneal implant may also comprise haptic leg(s) extending from the central region.